Transvenous vs. subcutaneous ICDs after transvenous device complication

por Willy, K, Frommeyer, G, Wolfes, J, Ellermann, C, Wegner, F K, Rath, B, Koebe, J, Reinke, F, Eckardt, L
Publicado 2023

Device updates successfully reduce T‑wave oversensing and inappropriate shocks in subcutaneous ICD patients

por Larbig, R., Motloch, L. J., Bettin, M., Fischer, A., Bode, N., Frommeyer, G., Loeher, A., Koebe, J., Reinke, F., Eckardt, L.
Publicado 2018

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

por Van den Brande, J, Schöffski, P, Schellens, J H M, Roth, A D, Duffaud, F, Weigang-Köhler, K, Reinke, F, Wanders, J, de Boer, R F, Vermorken, J B, Fumoleau, P
Publicado 2003